Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Graves' Orbitopathy and Hypercholesterolemia
A completed clinical trial sponsored by the University of Pisa investigated Graves' orbitopathy and hypercholesterolemia.
-
FDA approval · 2017-08-04FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for Lovastatin (generic statin). The approval pertains to changes under the AND…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Replacement of Saturated Fat in Dairy on Total Cholesterol [NA]
A completed clinical trial evaluated whether replacing saturated fat in dairy products with unsaturated fats affects total cholesterol in in…
-
FDA approval · 2017-07-11FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for pravastatin sodium (a generic statin product).
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan [Phase 3]
This is a Phase 3 trial evaluating alirocumab added to lipid-modifying therapy in high cardiovascular risk patients with hypercholesterolemi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Genetically Guided Statin Therapy [NA]
This clinical trial update describes the completion and posted results of a Duke-led study evaluating genetically guided statin therapy for …
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383) [Phase 3]
Phase 3 clinical trial evaluating MK-0653C in Japanese participants with hypercholesterolemia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: A Study of LY3015014 in Participants With High Cholesterol [Phase 2]
Phase 2 trial update for LY3015014 in participants with high cholesterol (hypercholesterolemia) has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Acotral® Versus Zetia® Ezetimibe Bioequivalance Study. [Phase 1]
A Phase 1 bioequivalence study comparing Acotral with Zetia (ezetimibe) in hypercholesterolemia, with the trial status reported as completed…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Rosuvastatin Calcium Bioequivalence Study - Fast [Phase 1]
Phase 1 bioequivalence study of rosuvastatin calcium completed for hypercholesterolemia.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia [Phase 2]
This entry reports on a Phase 2 clinical trial evaluating the safety and efficacy of CAT-2054 in combination with atorvastatin for hyperchol…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Effect of Crestor on Lipoprotein Metabolism in Humans [Phase 4]
The document reports the completion of a Phase 4 trial evaluating the effects of rosuvastatin (Crestor) on lipoprotein metabolism in humans …
-
FDA approval · 2017-06-12FDA Approved: EZETIMIBE — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's original application for ezetimibe, a generic cholesterol-lowering medication. The approval confirms marketing aut…
-
CLINICAL_TRIALS withdrawal · 2017-06-05Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DP-R212 [Phase 3]
A Phase 3 clinical trial evaluating DP-R212 for hypertension and hypercholesterolemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles [NA]
A defined, plant-based, four-week dietary intervention reduced Lp(a) and other atherogenic particles in adults with hypercholesterolemia, ac…
-
FDA approval · 2017-05-25FDA Approved: COLESTID — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for COLESTID (colestipol hydrochloride) submitted by Pharmacia & Upjohn Company LLC.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Effects of a 4-week Raw, Plant-based Diet on Anthropometric and Cardiovascular Risk Factors [NA]
A completed study evaluated the impact of a 4-week raw, plant-based diet on anthropometric measures and cardiovascular risk factors.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol [Phase 1]
Phase 1 trial evaluating the effect of Alirocumab on lipid metabolism in adults with elevated LDL-cholesterol has completed. The study asses…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS) [NA]
The record notes the completed trial of wheat bran extract on gut and general health in healthy aging adults. The snippet does not include r…
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Magnetic Resonance Imaging-Portfolio Diet Study #7 [NA]
This document reports the withdrawal of Clinical Trial Update: Magnetic Resonance Imaging-Portfolio Diet Study #7, sponsored by Unity Health…
-
CLINICAL_TRIALS withdrawal · 2017-04-26Clinical Trial Update: Enhanced Multicenter Dietary Portfolio Study [NA]
The Enhanced Multicenter Dietary Portfolio Study has been withdrawn. It involved conditions including cardiovascular diseases, Type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021) [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of adding Anacetrapib to ongoing statin therapy in hypercholesterolemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS [NA]
A completed clinical trial evaluated the effect of ubiquinol on mitochondrial oxidative capacity in statin users and posted results.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED) [Phase 2]
This update summarizes the completed Phase 2 efficacy study (0524A-026) of MK0524A for hypercholesterolemia.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Lipid Efficacy Study (0524B-022)(COMPLETED) [Phase 3]
A Phase 3 lipid efficacy trial sponsored by Merck Sharp & Dohme LLC has completed (Study 0524B-022) for primary hypercholesterolemia and mix…